Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The combination of carboplatin and weekly paclitaxel: a safe and active regimen in advanced non small-cell lung cancer patients. A phase I-II study.
Fabi A, Barduagni M, Ferraresi V, Cortesi E, Gamucci T, De Marinis F, Saltarelli R, Gabriele A, Pellicciotta M, Ceribelli A, De Marco S, Facciolo F, Cognetti F. Fabi A, et al. Among authors: ceribelli a. J Exp Clin Cancer Res. 2004 Mar;23(1):25-32. J Exp Clin Cancer Res. 2004. PMID: 15149147 Clinical Trial.
A phase II study of biweekly paclitaxel (P) and gemcitabine (G), followed by maintenance weekly paclitaxel in elderly patients with advanced non-small cell lung cancer (NSCLC).
Pino MS, Gamucci T, Mansueto G, Trapasso T, Narducci F, Giampaolo MA, Fariello AM, Sperduti I, Ceribelli A, Cognetti F. Pino MS, et al. Among authors: ceribelli a. Lung Cancer. 2008 Jun;60(3):381-6. doi: 10.1016/j.lungcan.2007.10.027. Epub 2007 Dec 19. Lung Cancer. 2008. PMID: 18068853 Clinical Trial.
The serine protease HtrA1 is a novel prognostic factor for human mesothelioma.
Baldi A, Mottolese M, Vincenzi B, Campioni M, Mellone P, Di Marino M, di Crescenzo VG, Visca P, Menegozzo S, Spugnini EP, Citro G, Ceribelli A, Mirri A, Chien J, Shridhar V, Ehrmann M, Santini M, Facciolo F. Baldi A, et al. Among authors: ceribelli a. Pharmacogenomics. 2008 Aug;9(8):1069-77. doi: 10.2217/14622416.9.8.1069. Pharmacogenomics. 2008. PMID: 18681782
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer.
Bria E, Milella M, Sperduti I, Alessandrini G, Visca P, Corzani F, Giannarelli D, Cerasoli V, Cuppone F, Cecere FL, Marchetti A, Sacco R, Mucilli F, Malatesta S, Guetti L, Vitale L, Ceribelli A, Rinaldi M, Terzoli E, Cognetti F, Facciolo F. Bria E, et al. Among authors: ceribelli a. Lung Cancer. 2009 Dec;66(3):365-71. doi: 10.1016/j.lungcan.2009.02.024. Epub 2009 Mar 27. Lung Cancer. 2009. PMID: 19327866
Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs).
Palmieri G, Merola G, Federico P, Petillo L, Marino M, Lalle M, Milella M, Ceribelli A, Montella L, Merola C, Del Prete S, Bergaglio M, De Placido S, Di Lorenzo G. Palmieri G, et al. Among authors: ceribelli a. Ann Oncol. 2010 Jun;21(6):1168-1172. doi: 10.1093/annonc/mdp483. Epub 2009 Oct 30. Ann Oncol. 2010. PMID: 19880439 Free article. Clinical Trial.
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis.
Bria E, Milella M, Cuppone F, Novello S, Ceribelli A, Vaccaro V, Sperduti I, Gelibter A, Scagliotti GV, Cognetti F, Giannarelli D. Bria E, et al. Among authors: ceribelli a. Ann Oncol. 2011 Oct;22(10):2277-85. doi: 10.1093/annonc/mdq742. Epub 2011 Feb 16. Ann Oncol. 2011. PMID: 21325444 Free PMC article. Review.
169 results